SOM Biotech was one of the companies invited to the Private Chinese-Swiss Investor Collaborations Forum that took place in Zurich on September 11th 2017.

Dr. Insa (CEO) and Dr. Palazzesi (Senior Computational Chemist) were in charge to present Company’s Strategy and Assets to the large Chinese delegation interested in knowing and investing in health-care EU companies.

Opportunities of EU-China collaborations were also discussed between the innovative presenting companies and Chinese representatives.





    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.